TREA

97301650 - MTYEKA

Follow

Information

  • Trademark
  • 97301650
  • Serial Number
    97301650
  • Filing Date
    March 08, 2022
    2 years ago
  • Transaction Date
    November 26, 2024
    a month ago
  • Status Date
    June 27, 2024
    6 months ago
  • Published for Opposition Date
    May 02, 2023
    a year ago
  • Location Date
    June 27, 2023
    a year ago
  • Status Code
    731
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    SINGLETON, RUDY
  • Attorney Docket Number
    00163829-US
    Attorney Name
    Marilyn F. Kelly
    Law Office Assigned Location Code
    L20
  • Owners
Information
Mark Drawing Code
4
Mark Identification
MTYEKA
Case File Statements
  • GS0051: pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of bladder cancer; pharmaceutical preparations for the treatment of lung cancer; pharmaceutical preparations for the treatment of renal cancer; pharmaceutical preparations for the treatment of renal cell carcinoma; pharmaceutical preparations for the treatment of squamous cell carcinoma; pharmaceutical preparations for the treatment of head and neck squamous cell carcinoma; pharmaceutical preparations for the treatment of oral cavity squamous cell carcinoma; pharmaceutical preparations for the treatment of colorectal cancer; pharmaceuticals comprising small molecules for the treatment of cancer; pharmaceuticals comprising small molecules for the treatment of bladder cancer; pharmaceuticals comprising small molecules for the treatment of lung cancer; pharmaceuticals comprising small molecules for the treatment of renal cancer; pharmaceuticals comprising small molecules for the treatment of renal cell carcinoma; pharmaceuticals comprising small molecules for the treatment of squamous cell carcinoma; pharmaceuticals comprising small molecules for the treatment of head and neck squamous cell carcinoma; pharmaceuticals comprising small molecules for the treatment of oral cavity squamous cell carcinoma; pharmaceuticals comprising small molecules for the treatment of colorectal cancer; pharmaceutical products for the treatment of cancer; pharmaceutical products for use in oncology; pharmaceutical products for the treatment of infectious diseases; pharmaceutical products for the treatment of bladder cancer; pharmaceutical products for the treatment of lung cancer; pharmaceutical products for the treatment of renal cancer; pharmaceutical products for the treatment of renal cell carcinoma; pharmaceutical products for the treatment of squamous cell carcinoma; pharmaceutical products for the treatment of head and neck squamous cell carcinoma; pharmaceutical products for the treatment of oral cavity squamous cell carcinoma; pharmaceutical products for the treatment of colorectal cancer; pharmaceuticals comprising compounds for the treatment of cancer; pharmaceuticals comprising inhibitors for the treatment of cancer; pharmaceuticals for the treatment of solid tumors
  • GS0421: research and development of pharmaceuticals in the field of oncology; providing information in the field of scientific and medical research related to oncology; research and development of pharmaceuticals; providing information in the field of scientific and medical research related to pharmaceuticals
Case File Event Statements
  • 9/29/2022 - 2 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 3/11/2022 - 2 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 3/14/2022 - 2 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 9/28/2022 - 2 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 9/29/2022 - 2 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 9/29/2022 - 2 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 3/6/2023 - a year ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 3/6/2023 - a year ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 3/7/2023 - a year ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 3/24/2023 - a year ago
    10 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 4/12/2023 - a year ago
    11 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 5/2/2023 - a year ago
    12 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 6/27/2023 - a year ago
    14 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 12/14/2023 - a year ago
    15 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 12/14/2023 - a year ago
    16 - SOU EXTENSION 1 FILED Type: EXT1
  • 12/14/2023 - a year ago
    17 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 12/16/2023 - a year ago
    18 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 5/2/2023 - a year ago
    13 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 6/27/2024 - 6 months ago
    20 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 6/27/2024 - 6 months ago
    19 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 6/27/2024 - 6 months ago
    21 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 6/27/2024 - 6 months ago
    22 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 6/27/2024 - 6 months ago
    25 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 6/27/2024 - 6 months ago
    24 - SOU EXTENSION 2 GRANTED Type: EX2G
  • 6/27/2024 - 6 months ago
    23 - SOU EXTENSION 2 FILED Type: EXT2
  • 11/25/2024 - a month ago
    26 - SOU TEAS EXTENSION RECEIVED Type: EEXT